跳至主要内容
临床试验/CTRI/2011/11/002138
CTRI/2011/11/002138招募中4 期

A Pilot Study To Evaluate The Effect Of N-Acetyl Cysteine (NAC) On The Bronchodilator Response With Inhaled Salbutamol And Ipratropium In Patients With Chronic Obstructive Pulmonary Disease (COPD)

Cipla Ltd0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
Cipla Ltd
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Adult males or females with a diagnosis of Chronic Obstructive Pulmonary Disease
  • COPD defined as FEV1/FVC < 0.7 and FEV1 < 80% predicted

排除标准

  • Previous history of diagnosis of asthma
  • Previous history of atopy except controlled allergic rhinitis
  • History of concomitant pulmonary disease
  • Patients with bronchogenic carcinoma
  • Patients having known hypersensitivity to NAC
  • Patients with peripheral eosinophill count more than 600/µl of blood.
  • Patients already on NAC therapy or any mucolytic agent
  • Patients having history suggestive of high antioxidant intake through nutritional route
  • COPD with exacerbation within the previous three months requiring oral steroids, nebulised bronchodilator, antibiotics or an emergency visit to the doctor
  • Patients having uncontrolled allergic rhinitis
  • In the opinion of the investigator the patient would not be able to comply with the study procedures

研究者

发起方
Cipla Ltd

相似试验